Results
|
|
681.
|
|
|
|
682.
|
|
|
|
683.
|
|
|
|
684.
|
|
|
|
685.
|
|
|
|
686.
|
|
|
|
687.
|
|
|
|
688.
|
|
|
|
689.
|
|
|
|
690.
|
|
|
|
691.
|
|
|
|
692.
|
|
|
|
693.
|
|
|
|
694.
|
|
|
|
695.
|
|
|
|
696.
|
|
|
|
697.
|
|
|
|
698.
|
|
|
|
699.
|
|
|
|
700.
|
Discovery of 2-(2-chlorophenyl)-3-(4-chlorophenyl)-7-(2,2-difluoropropyl)-6,7-dihydro-2H-pyrazolo[3,4-f][1,4]oxazepin-8(5H)-one (PF-514273), a novel, bicyclic lactam-based cannabinoid-1 receptor antagonist for the treatment of obesity. [electronic resource] by
- Dow, Robert L
- Carpino, Philip A
- Hadcock, John R
- Black, Shawn C
- Iredale, Philip A
- DaSilva-Jardine, Paul
- Schneider, Steven R
- Paight, Ernest S
- Griffith, David A
- Scott, Dennis O
- O'Connor, Rebecca E
- Nduaka, Chudy I
Producer: 20090602
In:
Journal of medicinal chemistry vol. 52
Availability: No items available.
|